Apple Watch Ultra 4: Redesign, Blood Pressure Monitoring, and More - FAQs

The upcoming Apple Watch Ultra 4 is generating buzz with rumors of a comprehensive overhaul and advanced health features. Based on reports from DigiTimes, this smartwatch is expected to debut in fall 2026 alongside other Apple products. Below, we answer the most pressing questions about its design, health monitoring capabilities, and market impact.

What redesign is expected for the Apple Watch Ultra 4?

According to DigiTimes, the Apple Watch Ultra 4 will undergo a full redesign, marking a significant departure from previous models. Reports indicate external changes, including a new arrangement of eight sensors on the back in a ring pattern. This redesign aims to enhance both aesthetics and functionality, moving beyond incremental updates. Industry observers believe these changes could boost Apple Watch shipments by 20-30% compared to 2025 levels. The overhaul is part of Apple’s strategy to differentiate the Ultra line and solidify its position in the premium wearable market.

How will blood pressure monitoring work on the Apple Watch Ultra 4?

The new blood pressure monitoring feature will leverage the optical heart-rate sensor on the back of the device. It analyzes how blood vessels respond to each heartbeat, detecting abnormal patterns that may indicate high blood pressure. When an irregular pattern is identified, the watch sends a notification alerting the user. Apple has reportedly submitted this feature to the FDA for review, suggesting a push toward clinical-grade accuracy. The system uses advanced algorithms to interpret sensor data, but specific details about trigger thresholds remain under wraps.

How does this differ from the existing Hypertension Notifications in watchOS 26?

While both features use the optical heart sensor, the new implementation on the Ultra 4 is more refined. The Hypertension Notifications introduced with watchOS 26 analyze blood vessel responses over 30-day periods to identify long-term trends. In contrast, the upcoming feature appears to offer real-time alerts based on individual heartbeat patterns, providing immediate notifications when abnormal readings occur. DigiTimes suggests that earlier Apple Watch models already had some blood-pressure sensing capabilities, but the Ultra 4 version represents a more clinically validated and precise application of the same underlying hardware.

What other health monitoring features are planned for future Apple Watches?

After implementing refined blood pressure monitoring, Apple’s next major health push will focus on noninvasive blood-glucose monitoring. This capability has been in development for several years and would allow users to track glucose levels without needles. However, it still requires government approval before launch. The timeline remains uncertain, but the technology is expected to be a game-changer for diabetes management. Apple continues to prioritize health innovations, with each new model building on the previous generation’s sensor suite.

What supply chain insights have emerged regarding the Ultra 4?

DigiTimes reports that Taiwan-Asia Semiconductor (TASC) is Apple’s exclusive supplier of sensor components for the Ultra 4. The sensor upgrades in the redesign are expected to result in large-volume orders for TASC, possibly as early as July 2025. This signals strong confidence in the new model’s demand. The supply chain also points to a “significant upgrade to sensing functions,” corroborating earlier rumors about the ring-shaped sensor array. These developments suggest Apple is investing heavily in component quality and manufacturing capacity.

When will the Apple Watch Ultra 4 be announced?

The Apple Watch Ultra 4 is expected to be announced in fall 2026, alongside the Apple Watch Series 12, iPhone 18 Pro, iPhone 18 Pro Max, and a rumored foldable “iPhone Ultra.” This timeline aligns with Apple’s typical September product events. While specific dates are unconfirmed, industry watchers anticipate a launch within the usual September-October window. The delay from earlier expectations may be due to the extensive redesign and new health feature certifications.

How will the redesign and blood pressure features impact Apple Watch sales?

Market analysts cited by DigiTimes predict the Ultra 4’s redesign and sensor upgrades could boost Apple Watch shipments by 20-30% compared to 2025 levels. The new health features, particularly blood pressure monitoring, are expected to attract both existing users upgrading and new customers focused on wellness. The premium Ultra line has positioned itself as a rugged, health-oriented wearable, and these additions reinforce that identity. If the FDA approves the blood pressure feature, it could set a new standard for smartwatch health monitoring, driving significant competitive advantage and sales growth.